Transcriptomics

Dataset Information

0

TGF-βRII/IL-15 Immunotherapeutic complex targets exhausted CD8+ T cell subsets in lymph nodes and tumors


ABSTRACT: Exhausted CD8+ T cells, located within the tumor-draining lymph nodes (TDLNs) are responsible for maintaining tumor-specific responses in cancer. Here, we demonstrate that a bifunctional TGF-βRII/IL-15 protein complex (HCW9218), with TGF-β neutralization and IL-15 immunostimulatory activities, is capable of localizing to the TDLNs and tumors after subcutaneous administration, neutralizes TGF-β, expands progenitor stem-like exhausted T cells (TPEX) in TDLNs, and promotes their infiltration into tumors. Immune-checkpoint-inhibitors (ICIs) significantly enhanced the effects of HCW9218 on TPEX, and synergistically improved HCW9218 anti-tumor efficacy in melanoma and reduced spontaneous lung metastasis in breast cancer models. In a dose-escalating clinical trial in patients with chemo-refractory/relapsed solid tumors, HCW9218 monotherapy was well-tolerated, reduced serum TGF-β levels, promoted CD8+ T cell expansion in peripheral blood and CD8+ T cell infiltration in tumor biopsies. These findings provide a strong basis for using HCW9218 to enhance the efficacy of ICIs against solid tumors in the clinical setting.

ORGANISM(S): Mus musculus

PROVIDER: GSE301523 | GEO | 2025/07/07

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2025-07-08 | GSE301591 | GEO
2025-05-30 | GSE298159 | GEO
2025-05-27 | GSE253205 | GEO
2025-05-27 | GSE253487 | GEO
2024-05-09 | GSE266287 | GEO
2024-05-09 | GSE266286 | GEO
2025-07-07 | GSE288889 | GEO
2025-07-07 | GSE270420 | GEO
2025-03-17 | GSE271477 | GEO
2023-05-30 | GSE233388 | GEO